Shilan Mozaffari

1.0k total citations
26 papers, 791 citations indexed

About

Shilan Mozaffari is a scholar working on Gastroenterology, Genetics and Surgery. According to data from OpenAlex, Shilan Mozaffari has authored 26 papers receiving a total of 791 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Gastroenterology, 7 papers in Genetics and 5 papers in Surgery. Recurrent topics in Shilan Mozaffari's work include Gastrointestinal motility and disorders (13 papers), Inflammatory Bowel Disease (5 papers) and Gut microbiota and health (4 papers). Shilan Mozaffari is often cited by papers focused on Gastrointestinal motility and disorders (13 papers), Inflammatory Bowel Disease (5 papers) and Gut microbiota and health (4 papers). Shilan Mozaffari collaborates with scholars based in Iran, New Zealand and South Korea. Shilan Mozaffari's co-authors include Mohammad Abdollahı, Shekoufeh Nikfar, Roja Rahimi, Tina Didari, Amir Hossein Abdolghaffari, Maryam Baeeri, Marzieh Daniali, Hadi Esmaily, Hamid Reza Monsef-Esfahani and Reza Hajiaghaee and has published in prestigious journals such as Current Pharmaceutical Design, Digestive Diseases and Sciences and Expert Opinion on Investigational Drugs.

In The Last Decade

Shilan Mozaffari

26 papers receiving 749 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shilan Mozaffari Iran 15 222 180 160 128 122 26 791
Małgorzata Zwolińska-Wcisło Poland 17 301 1.4× 179 1.0× 119 0.7× 197 1.5× 256 2.1× 62 929
Tina Didari Iran 9 343 1.5× 222 1.2× 178 1.1× 48 0.4× 99 0.8× 14 742
Emilie Mérour France 6 434 2.0× 290 1.6× 129 0.8× 58 0.5× 106 0.9× 8 906
Pauline M. Anton France 18 366 1.6× 157 0.9× 181 1.1× 100 0.8× 189 1.5× 51 1.5k
Marcella Pesce Italy 24 371 1.7× 336 1.9× 60 0.4× 84 0.7× 345 2.8× 66 1.3k
Abigail Basson United States 16 301 1.4× 61 0.3× 73 0.5× 155 1.2× 84 0.7× 35 672
Luisa Seguella Italy 21 431 1.9× 280 1.6× 56 0.3× 104 0.8× 229 1.9× 47 1.1k
Andrea Kodde Netherlands 9 369 1.7× 57 0.3× 155 1.0× 93 0.7× 66 0.5× 14 708
Przemysław Tomasik Poland 16 326 1.5× 50 0.3× 262 1.6× 173 1.4× 157 1.3× 78 1.1k
Faith D. Ihekweazu United States 11 461 2.1× 76 0.4× 127 0.8× 117 0.9× 72 0.6× 25 736

Countries citing papers authored by Shilan Mozaffari

Since Specialization
Citations

This map shows the geographic impact of Shilan Mozaffari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shilan Mozaffari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shilan Mozaffari more than expected).

Fields of papers citing papers by Shilan Mozaffari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shilan Mozaffari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shilan Mozaffari. The network helps show where Shilan Mozaffari may publish in the future.

Co-authorship network of co-authors of Shilan Mozaffari

This figure shows the co-authorship network connecting the top 25 collaborators of Shilan Mozaffari. A scholar is included among the top collaborators of Shilan Mozaffari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shilan Mozaffari. Shilan Mozaffari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mozaffari, Shilan, Mohammad Sadegh Hassanvand, Maryam Baeeri, et al.. (2025). Exploring the impact of ambient air PM 2.5 on multiple sclerosis: an experimental dive into neuroinflammation. Toxicology Mechanisms and Methods. 35(6). 581–591. 1 indexed citations
2.
Mozaffari, Shilan, Shekoufeh Nikfar, Marzieh Daniali, & Mohammad Abdollahı. (2020). The pharmacological management of constipation in patients with Parkinson’s disease: a much-needed relief. Expert Opinion on Pharmacotherapy. 21(6). 701–707. 19 indexed citations
3.
Dellis, Athanasios, Shilan Mozaffari, Shekoufeh Nikfar, Athanasios Papatsoris, & Mohammad Abdollahı. (2018). Is there an appropriate strategy for treating co-morbid irritable bowel syndrome and bladder pain syndrome?. Expert Opinion on Pharmacotherapy. 20(4). 411–414. 5 indexed citations
4.
Mozaffari, Shilan, Shekoufeh Nikfar, & Mohammad Abdollahı. (2018). Methylnaltrexone bromide for the treatment of opioid-induced constipation. Expert Opinion on Pharmacotherapy. 19(10). 1127–1135. 8 indexed citations
5.
Nikfar, Shekoufeh, et al.. (2017). Tumor necrosis factor-alpha antibodies in fistulizing crohn's disease: An updated systematic review and meta-analysis. Journal of Research in Pharmacy Practice. 6(3). 135–135. 5 indexed citations
6.
Esmaily, Hadi, et al.. (2014). Induction of Inflammatory Bowel Disease Through Activation of Immune System Against Enteric Bacteria. Journal of Gastroenterology and Hepatology Research. 3(2). 977–984. 1 indexed citations
7.
Mozaffari, Shilan, Shekoufeh Nikfar, & Mohammad Abdollahı. (2014). The safety of novel drugs used to treat irritable bowel syndrome. Expert Opinion on Drug Safety. 13(5). 625–638. 14 indexed citations
8.
Mozaffari, Shilan, Tina Didari, Shekoufeh Nikfar, & Mohammad Abdollahı. (2014). Phase II drugs under clinical investigation for the treatment of chronic constipation. Expert Opinion on Investigational Drugs. 23(11). 1485–1497. 20 indexed citations
9.
Mozaffari, Shilan, Shekoufeh Nikfar, Amir Hossein Abdolghaffari, & Mohammad Abdollahı. (2014). New biologic therapeutics for ulcerative colitis and Crohn's disease. Expert Opinion on Biological Therapy. 14(5). 583–600. 49 indexed citations
10.
Didari, Tina, et al.. (2014). A systematic review of the safety of probiotics. Expert Opinion on Drug Safety. 13(2). 227–239. 257 indexed citations
11.
Mozaffari, Shilan, Shekoufeh Nikfar, & Mohammad Abdollahı. (2014). Systematic review/Meta-analysis Efficacy and tolerability of renzapride in irritable bowel syndrome: a meta-analysis of randomized, controlled clinical trials including 2528 patients. Archives of Medical Science. 1(1). 10–18. 10 indexed citations
12.
Mozaffari, Shilan, Amir Hossein Abdolghaffari, Shekoufeh Nikfar, & Mohammad Abdollahı. (2014). Pregnancy outcomes in women with inflammatory bowel disease following exposure to thiopurines and antitumor necrosis factor drugs. Human & Experimental Toxicology. 34(5). 445–459. 33 indexed citations
13.
Mozaffari, Shilan, et al.. (2013). Synergistic effect of probiotics, butyrate and l-Carnitine in treatment of IBD. 7(2). 50–53. 21 indexed citations
14.
Mozaffari, Shilan, Shekoufeh Nikfar, & Mohammad Abdollahı. (2013). Metabolic and toxicological considerations for the latest drugs used to treat irritable bowel syndrome. Expert Opinion on Drug Metabolism & Toxicology. 9(4). 403–421. 14 indexed citations
15.
Mozaffari, Shilan, et al.. (2012). Benefit of Aloe vera and Matricaria recutita mixture in rat irritable bowel syndrome: Combination of antioxidant and spasmolytic effects. Chinese Journal of Integrative Medicine. 26 indexed citations
16.
Mozaffari, Shilan, et al.. (2012). The Mechanisms of Positive Effects of Melatonin in Dyslipidemia: A Systematic Review of Animal and Human Studies. International Journal of Pharmacology. 8(6). 496–509. 14 indexed citations
17.
Abdollahı, Mohammad, et al.. (2011). Effects of Hypericum perforatum extract on rat irritable bowel syndrome. Pharmacognosy Magazine. 7(27). 213–213. 40 indexed citations
18.
Mozaffari, Shilan & Mohammad Abdollahı. (2011). Melatonin, a Promising Supplement in Inflammatory Bowel Disease: A Comprehensive Review of Evidences. Current Pharmaceutical Design. 17(38). 4372–4378. 46 indexed citations
19.
Mozaffari, Shilan, Roja Rahimi, & Mohammad Abdollahı. (2010). Implications of Melatonin Therapy in Irritable Bowel Syndrome: A Systematic Review. Current Pharmaceutical Design. 16(33). 3646–3655. 58 indexed citations
20.
Rahimi, Roja, Shilan Mozaffari, & Mohammad Abdollahı. (2008). On the Use of Herbal Medicines in Management of Inflammatory Bowel Diseases: A Systematic Review of Animal and Human Studies. Digestive Diseases and Sciences. 54(3). 471–480. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Małgorzata Zwolińska-Wcisło Breakdown of academic impact, for papers by Tina Didari Breakdown of academic impact, for papers by Emilie Mérour Breakdown of academic impact, for papers by Pauline M. Anton Breakdown of academic impact, for papers by Marcella Pesce Breakdown of academic impact, for papers by Abigail Basson Breakdown of academic impact, for papers by Luisa Seguella Breakdown of academic impact, for papers by Andrea Kodde Breakdown of academic impact, for papers by Przemysław Tomasik Breakdown of academic impact, for papers by Faith D. Ihekweazu
Rankless by CCL
2026